会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明公开
    • 4-ARYLMETHYLOXYMETHYL PIPERIDINES AS TACHYKININ ANTAGONISTS
    • 4- AKYLMETHYLOXYMETHYL PIPERIDINE拮抗剂作为速激肽。
    • EP0666856A1
    • 1995-08-16
    • EP93923630.0
    • 1993-10-27
    • MERCK SHARP & DOHME LTD.
    • HARRISON, TimothyMACLEOD, Angus Murray, 24 Abbotts WaySTEVENSON, Graeme IrvineWILLIAMS, Brian John
    • C07D211A61K31A61P1A61P9A61P11A61P13A61P15A61P25A61P29A61P35A61P37A61P43C07D207C07D213C07D401C07D413C07D417C07D521
    • C07D207/08C07D211/22C07D211/96C07D231/12C07D233/56C07D249/08C07D401/06C07D401/12C07D413/06C07D417/06
    • Compounds of formula (I) wherein m is 2, 3 or 4; n is 0, 1 or 2 when m is 2 or 3, and n is 0 or 1 when m is 4; X represents O or S; R1 represents phenyl optionally substituted by 1, 2 or 3 groups selected from C¿1-6?alkyl, C2-6alkenyl, C2-6alkynyl, halo, cyano, nitro, trifluoromethyl, trimethylsilyl, -OR?a, SRa, SORa, SO¿2R?a, -NRaRb, -NRaCORb, -NRaCO¿2Rb, -CO2Ra or -CONRaRb, where R?a and Rb¿ each independently represent H, C¿1-6?alkyl, phenyl or trifluoromethyl; R?2¿ represents phenyl optionally substituted by 1, 2 or 3 groups selected from C¿1-6?alkyl, C2-6alkenyl, C2-6alkynyl, halo, cyano, nitro, trifluoromethyl, trimethylsilyl, -OR?a, SRa, SORa, SO¿2R?a, -NRaRb, -NRaCORb, -NRaCO¿2Rb, -CO2Ra or -CONRaRb, where R?a and Rb¿ are as previously defined; heteroaryl selected from indazolyl, thienyl, furyl, pyridyl, thiazolyl, tetrazolyl and quinolyl; benzhydryl; or benzyl; wherein each heteroaryl and each phenyl moiety of benzyl and benzhydryl may be substituted by C¿1-6?alkyl, C1-6alkoxy, halo or trifluoromethyl; and R?3¿ represents H, COR9, CO2R10, COCONR10R11, COCO¿2?R?10, SO¿2R?15, CONR10SO¿2R15, C1-6alkyl optionally substituted by a group selected from (CO2R?10, CONR10R11¿, hydroxy, cyano, COR?9, NR10R11¿, C(NOH)NR10R11, CONHphenyl(C¿1-4?alkyl), COCO2R?10¿, COCONR?10R11, SO¿2R?15, CONR10SO¿2R15 and phenyl optionally substituted by one or more substituents selected from C¿1-6?alkyl, C1-6alkoxy, halo and trifluoromethyl), Y-R?8¿ or CO-Z-(CH¿2?)q-R?12; R4, R5, R6 and R7¿ each independently represent H or C¿1-6?alkyl; R?8¿ represents an optionally substituted aromatic heterocycle; R9 represents H, C¿1-6?alkyl or phenyl; R?10 and R11¿ each independently represent H or C¿1-6?alkyl; R?12¿ represents NR13R14 or an optionally substituted aromatic or non-aromatic azacyclic or azabicyclic group; R?13 and R14¿ each independently represent H, C¿1-6?alkyl, phenyl optionally substituted by one or more of C1-6alkyl, C1-6alkoxy, halo or trifluoromethyl or phenylC1-4alkyl optionally substituted in the phenyl ring by one or more of C1-6alkyl, C1-6alkoxy, halo or trifluoromethyl; R?15¿ represents C¿1-6?alkyl, trifluoromethyl or phenyl optionally substituted by one or more substituents selected from C1-6alkyl, C1-6alkoxy, halo and trifluoromethyl; Y represents a hydrocarbon chain of 1, 2, 3 or 4 carbon atoms which way optionally be substituted by oxo; Z represents CH2, O, S or NR?10¿; and q represents 0, 1, 2, 3, 4, 5 or 6 and their salts are useful as tachykinin antagonists.